Alphora Research, Inc. has invested in a new pilot plant facility in an effort to increase its range of services. The company recently expanded to include a 14,000-sq.-ft. facility. The cGMP pilot plant is currently under construction and is expected to be finished by the end of the year. This facility includes 200L and 400L glass lined reactors, with temperature ranges of cryogenic (-80C) to 200C, as well as support process equipment. Support functions will include warehousing and quality control capabilities.

The company currently operates a cGMP Kilo lab facility, which has completed a number of clinical stage projects, and is currently validating one product for commercial supply. The new pilot plant will allow the company to supply larger quantities of clinical API materials and niche commercial products.

Alphora’s operations include synthetic laboratories, analytical laboratories, cGMP stability studies and cGMP kilo laboratories.